Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials. - Wikidata - wikimedia - TriplyDB

Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials.

Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials.

http://www.wikidata.org/entity/Q38391306

about

Neural Correlates for Apathy: Frontal-Prefrontal and Parietal Cortical- Subcortical Circuits Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease : A systematic review across modalities Motivational processes in mild cognitive impairment and Alzheimer's disease: results from the Motivational Reserve in Alzheimer's (MoReA) study Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial.Preliminary Evidence of Apathetic-Like Behavior in Aged Vesicular Monoamine Transporter 2 Deficient Mice.Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson's Dementia Complex: New Aspects for This Riddle.Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments.Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis.Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.Determination of Aerobic Capacity via Cycle Ergometer Exercise Testing in Alzheimer's Disease.State of the Science: Apathy As a Model for Investigating Behavioral and Psychological Symptoms in Dementia.

P2860

Q28069542-9F395E1A-D0F1-442E-8CA8-1557864DDA4D Q34552380-077D243D-2E0C-4B35-91B4-56AECB53AD6D Q35844446-C014472A-C1EE-4E5C-9556-5ED6133B207A Q36316344-F1E522F5-0E38-428F-AE9A-DC0B32EEC705 Q37421148-B62996F1-8CBB-4D50-BB28-6260365EABE9 Q37733592-B2DDB946-70D6-4F04-93E8-933D0E5D9283 Q38977500-5CEC8A4E-F334-46E7-8AF2-A34D70534A52 Q38985928-A07C41F2-EDE7-478B-8705-1FA858DAFCEC Q47764486-A777E6D0-DB56-4FC5-982F-3F6AF88E6182 Q51809127-ABCDA274-4815-44F7-BAF7-37581EA3199C Q52691287-AE5BF9FE-CF3F-4BF6-B7D9-75CAA03305C2

P2860

Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials.

http://www.wikidata.org/entity/Q38391306

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials.

@en

type

label

Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials.

@en

prefLabel

Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials.

@en

P1433

Q38391306-3650DEEF-2595-4E60-80CD-A0666AA80805

P1476

Q38391306-34162743-9C22-4584-B422-867A4B9AF56E

P2093

Q38391306-2F5B683E-4C7E-4892-94CC-823F9F2FD11E

Q38391306-32BE7CB6-E506-4302-ADDD-4360D88D0E48

Q38391306-67925709-E253-4A96-9D9A-785CF5252796

Q38391306-6FC96259-9100-47BC-BB22-16866E0456D5

Q38391306-BB3C260B-0CF6-4960-A658-B9E0CEC81348

P2860

Q38391306-047867C7-9291-4F56-8D90-6AE1DD0CAF02

Q38391306-08B7F9B5-20D9-4C45-930D-955100DC4918

Q38391306-08C76AD4-FACB-45E9-9AA1-A975508379C9

Q38391306-0B1A9A7E-8F76-4D6A-AEF1-A4D1C58097C0

Q38391306-0B24621E-B7AA-4684-A4A5-E1D08BD46815

Q38391306-0D7BE264-315C-47FD-BD3E-DCBCBA3A57A8

Q38391306-0E54FC9A-FA2B-46F8-A517-71EC201C3C48

Q38391306-121EBC96-9367-48DB-A76A-EEAC870A37C8

Q38391306-15A1FE9C-A145-4421-A9B7-B6B2B8F255B9

Q38391306-17C5D04B-3ACA-4228-BFF8-36F3A479688D

P304

Q38391306-40070DB6-26CC-441D-AA15-1705A7637D9B

P31

Q38391306-272C2AA9-2F6E-4278-9085-608087327EDE

P356

Q38391306-09C71A97-9A9A-4EF7-8F0E-0FD24A9996BD

P433

Q38391306-BEC2800E-3146-48E2-8C1F-F7C15BFE1D53

P478

Q38391306-74FEB82A-0C22-4FD2-A84C-5FC4D7301392

P50

Q38391306-2A6A1CE2-D8C6-4ADA-8389-8BAD918D68F6

Q38391306-539403DC-F4E7-4441-9016-F82BF987C113

P577

Q38391306-4FC031AE-4B46-416D-A130-FE16B06FD0AF

P5875

Q38391306-B5F293BF-00D3-490F-AB63-F00AE24B2176

P698

Q38391306-A1378078-B3E7-4ED1-844B-738977D12BB9

P921

Q38391306-3B3642EB-B280-49EE-8398-58AE6A0EEEF5

P356

0891988715573534

P1433

Journal of Geriatric Psychiatry and Neurology

P1476

Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials.

@en

P2093

George Garibaldi

http://www.w3.org/2001/XMLSchema#string

Laura Marsh

http://www.w3.org/2001/XMLSchema#string

Martin Jones

http://www.w3.org/2001/XMLSchema#string

Philippe H Robert

http://www.w3.org/2001/XMLSchema#string

Wayne Macfadden

http://www.w3.org/2001/XMLSchema#string

P2860

Behavioral and psychological symptoms of dementia

Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress

“Mini-mental state”

The hospital anxiety and depression scale

A new method for measuring daytime sleepiness: the Epworth sleepiness scale

Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson's disease.

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

Negative symptoms: the 'pathology' of motivation and goal-directed behaviour.

The nosological position of apathy in clinical practice.

Dissociating apathy and depression in Parkinson disease.

P304

159-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0891988715573534

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Joseph H. Friedman

Jeffrey L. Cummings

P577

2015-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274092378

http://www.w3.org/2001/XMLSchema#string

P698

25809634

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration